HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Ca | - | 19 | - | - |
| Us | - | 19 | - | - |
| Total revenue | 43 | 49 | 51 | 182 |
| Cost of revenue | 96 | 121 | 187 | 118 |
| Gross (loss) profit | -53 | -72 | -136 | 64 |
| Amortization of intangible assets | - | - | 7 | 7 |
| Selling, general and administrative expenses | 2,447 | 2,994 | 2,850 | 2,457 |
| Research and development expenses | 822 | 945 | 1,077 | 870 |
| Total operating expenses | 3,269 | 3,939 | 3,934 | 3,334 |
| Loss from operations | -3,322 | -4,011 | -4,070 | -3,270 |
| Other income, net | - | 20 | 55 | 71 |
| Other (expense)/income, net | -420 | - | - | - |
| Interest expense, net | -628 | -6 | -1 | -5 |
| Change in fair value of derivative liability | -6,028 | 109 | 152 | 1,733 |
| Foreign exchange gain (loss) | 565 | 50 | 178 | -141 |
| Nonoperating income, net | -6,511 | 173 | 384 | 1,658 |
| Loss before provision for income taxes | -9,833 | -3,838 | -3,686 | -1,612 |
| Provision for income taxes | - | - | - | - |
| Net loss | -9,833 | -3,838 | -3,686 | -1,612 |
| Foreign currency translation adjustments | -577 | -51 | -182 | 140 |
| Comprehensive loss | -10,410 | -3,889 | -3,868 | -1,472 |
| Earnings per share, basic | -79.73 | -0.51 | -0.99 | -0.64 |
| Earnings per share, diluted | -79.73 | -0.51 | -0.99 | -0.64 |
| Weighted average number of shares outstanding, basic | 123,335 | 7,556,267 | 3,740,625 | 2,518,071 |
| Weighted average number of shares outstanding, diluted | 123,335 | 7,556,267 | 3,740,625 | 2,518,071 |